Pharmaceutical

Biotech execs say IRA is causing unintended effects for cancer drug development

IRA regulations have changed how pharma is approaching innovation in cancer drug discovery and development.

Feb 28, 2024 - 18:00
Biotech execs say IRA is causing unintended effects for cancer drug development
IRA regulations have changed how pharma is approaching innovation in cancer drug discovery and development.
Read the original article

Tags:

Previous Article

Biotechs heed political headwinds for drug pricing negotiations and partnerships

Next Article

Beyond approval: Patients pursue alternate paths to get rare disease treatments

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Attovia secures $105m to advance development of lead programmes

Attovia secures $105m to advance development of lead pr...

May 11, 2024

STAT+: DarioHealth acquires Twill, hoping it’s a shortcut to profitability

STAT+: DarioHealth acquires Twill, hoping it’s a shortc...

Feb 21, 2024

With cancer expected to surge 77% worldwide by 2050, an oncologist weighs in on global disparities

With cancer expected to surge 77% worldwide by 2050, an...

Feb 5, 2024